Raymond James Downgrades Quest Diagnostics (DGX) Two Notches to Underperform
Tweet Send to a FriendGet Alerts DGX Hot Sheet
Price: $60.69 +1.35%
Rating Summary:
3 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
3 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade DGX Now!
Raymond James downgraded Quest Diagnostics (NYSE: DGX) from Outperform to Underperform.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $54.67 yesterday, with a 52 week range of $45.13-$62.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $54.67 yesterday, with a 52 week range of $45.13-$62.32.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Macquarie Downgrades Barrick Gold (ABX) to Underperform
- SunTrust Robinson Humphrey Downgrades Stryker (SYK) to Reduce
- Baird Downgrades Brocade (BRCD) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond James
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
